Search Results

• • 45 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II

  Authors:Taku Inohara, Peter Shrader, Karen Pieper, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, et al.From:American Heart Journal (Vol. 213) Peer-Reviewed

  July 2019551 words Article

   Abstract Only

• Patient characteristics, care patterns, and outcomes of atrial fibrillation associated hospitalizations in patients with chronic kidney disease and end-stage renal disease.

  Authors:Nilay Kumar, Haolin Xu, Neetika Garg, Ambarish Pandey, Roland A Matsouaka, Michael E Field, et al.From:American Heart Journal (Vol. 242) Peer-Reviewed

  Dec. 2021544 words Report

   Abstract Only

• Periprocedural imaging and outcomes after catheter ablation of atrial fibrillation

  Authors:Benjamin A. Steinberg, Bradley G. Hammill, James P. Daubert, Tristram D. Bahnson, Pamela S. Douglas, Laura G. Qualls, et al.From:Heart (Vol. 100, Issue 23) Peer-Reviewed

  Dec. 1, 2014 Report

   Citation Only

• Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale; From the COMBINE AF (A Collaboration between Multiple institutions to Better Investigate Non-vitamin K antagonist oral anticoagulant use in Atrial Fibrillation) Investigators.

  Authors:Anthony P Carnicelli, Hwanhee Hong, Robert P Giugliano, Stuart J Connolly, John Eikelboom, Manesh R Patel, et al.From:American Heart Journal (Vol. 233) Peer-Reviewed

  Mar. 2021445 words Report

   Abstract Only

• QRS duration, bundle-branch block morphology, and outcomes among older patients with heart failure receiving cardiac resynchronization therapy

  Authors:Pamela N. Peterson, Lesley H. Curtis, Adrian F. Hernandez, Jonathan P. Piccini, Bradley G. Hammill, Paul A. Heidenreich, et al.From:JAMA, The Journal of the American Medical Association (Vol. 310, Issue 6) Peer-Reviewed

  Aug. 14, 201361 words Report

   Citation Only

• Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery

  Authors:Daniel J. Friedman, Jonathan P. Piccini, Tongrong Wang, Jiayin Zheng, S. Chris Malaisrie, David R. Holmes, et al.From:JAMA, The Journal of the American Medical Association (Vol. 319, Issue 4) Peer-Reviewed

  Jan. 23, 201850 words Report

   Citation Only

• A genotype-directed comparative effectiveness trial of Bucindolol and metoprolol succinate for prevention of symptomatic atrial fibrillation/atrial flutter in patients with heart failure: Rationale and design of the GENETIC-AF trial

  Authors:Jonathan P. Piccini, Stuart J. Connolly, William T. Abraham, Jeff S. Healey, Benjamin A. Steinberg, Hussein R. Al-Khalidi, et al.From:American Heart Journal (Vol. 199) Peer-Reviewed

  May 2018536 words Article

   Abstract Only

• Association between economic and arrhythmic burden of paroxysmal atrial fibrillation in patients with cardiac implanted electronic devices.

  Authors:Derek S. Chew, Zhen Li, Benjamin A. Steinberg, Emily O'Brien, Jessica Pritchard, T. Jared Bunch, et al.From:American Heart Journal (Vol. 244) Peer-Reviewed

  Feb. 2022495 words Clinical report

   Abstract Only

• Impact of the COVID-19 pandemic on patterns of outpatient cardiovascular care.

  Authors:Jedrek Wosik, Megan E.B. Clowse, Robert Overton, Bhargav Adagarla, Nicoleta Economou-Zavlanos, Joanna Cavalier, et al.From:American Heart Journal (Vol. 231) Peer-Reviewed

  Jan. 2021456 words Article

   Abstract Only

• Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban

  Authors:Gunter Breithardt, Helmut Baumgartner, Scott D Berkowitz, Anne S Hellkamp, Jonathan P Piccini, Yuliya Lokhnygina, et al.From:Heart (Vol. 102, Issue 13) Peer-Reviewed

  July 1, 2016 Report

   Citation Only

• Bimodal distribution of atrial fibrillation burden in 3 distinct cohorts: What is 'paroxysmal' atrial fibrillation?

  Authors:Benjamin A. Steinberg, Zhen Li, Peter Shrader, Derek S. Chew, T. Jared Bunch, Daniel B. Mark, et al.From:American Heart Journal (Vol. 244) Peer-Reviewed

  Feb. 2022375 words Report, Brief articl...

   Abstract Only

• Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial

  Authors:Kenneth W. Mahaffey, Daniel Wojdyla, Graeme J. Hankey, Harvey D. White, Christopher C. Nessel, Jonathan P. Piccini, et al.From:Annals of Internal Medicine (Vol. 158, Issue 12) Peer-Reviewed

  June 18, 2013326 words Author abstract, Rep...

   Abstract Only

• Heart rate is associated with progression of atrial fibrillation, independent of rhythm

  Authors:Fredrik Holmqvist, Sunghee Kim, Benjamin A Steinberg, James A Reiffel, Kenneth W Mahaffey, Bernard J Gersh, et al.From:Heart (Vol. 101, Issue 11) Peer-Reviewed

  June 1, 2015 Report

   Citation Only

• Adiponectin: an accurate biomarker for patients at risk for atrial fibrillation?

  Authors:Adam S Barnett and Jonathan P. Piccini, SrFrom:Heart (Vol. 101, Issue 17) Peer-Reviewed

  Sept. 1, 2015 Report

   Citation Only

• Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.

  Authors:Douglas L. Packer, Daniel B. Mark, Richard A. Robb, Kristi H. Monahan, Tristram D. Bahnson, Jeanne E. Poole, et al.From:JAMA, The Journal of the American Medical Association (Vol. 321, Issue 13) Peer-Reviewed

  Apr. 2, 201957 words Report

   Citation Only

• Rivaroxaban versus Warfarin in nonvalvular atrial fibrillation

  Authors:Manesh R. Patel, Kenneth W. Mahaffey, Jyotsana Garg, Guohua Pan, Daniel E. Singer, Werner Hacke, et al.From:The New England Journal of Medicine (Vol. 365, Issue 10) Peer-Reviewed

  Sept. 8, 201153 words Clinical report

   Citation Only

• Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation.

  Authors:Zak Loring, Peter Shrader, Larry A. Allen, Rosalia Blanco, Paul S. Chan, Michael D. Ezekowitz, et al.From:American Heart Journal (Vol. 219) Peer-Reviewed

  Jan. 2020525 words Article

   Abstract Only

• ECG interpretation in ST-elevation myocardial infarction: pattern recognition or caliper measurements?

  Authors:Jonathan P. Piccini and E. Magnus OhmanFrom:Heart (Vol. 95, Issue 4) Peer-Reviewed

  Feb. 15, 2009 Editorial

   Citation Only

• Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease

  Authors:Renato D. Lopes, Meena Rao, DaJuanicia N. Simon, Laine Thomas, Jack Ansell, Gregg C. Fonarow, et al.From:American Journal of Medicine (Vol. 129, Issue 6) Peer-Reviewed

  June 2016812 words Report

   Abstract Only

• Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study.

  Authors:Jonathan P Piccini, Valeria Caso, Stuart J Connolly, Keith A A Fox, Jonas Oldgren, W Schuyler Jones, et al.From:The Lancet (Vol. 399, Issue 10333) Peer-Reviewed

  Apr. 9, 20221,499 words Clinical report

   Abstract Only